digital currency list 2016- Top People also ask

Treasury bond futures rose by 1.04% for 30-year main contracts, 0.53% for 10-year main contracts, 0.32% for 5-year main contracts and 0.10% for 2-year main contracts.The Beijing Municipal Science and Technology Commission and Zhongguancun Management Committee investigated the brain-computer interface technology under Chengyitong. Recently, Li Junnan, Minister of the Frontier Department of Medical Center of Beijing Science and Technology Commission and Zhongguancun Management Committee, and Zheng Meng, Deputy Director of Daxing District Science and Technology Commission, and his party went to Beijing Naolin Technology Co., Ltd., a subsidiary of Chengyitong, to have in-depth exchanges on further promoting the development and application of brain-computer interface technology. According to reports, at present, the company has made a series of important technological breakthroughs, and has completed the trial production of three prototypes of nerve rehabilitation products based on brain-computer interface technology, namely, products based on visual evoked potential paradigm-brain-computer interface cognitive rehabilitation system, brain-computer interface hand function rehabilitation system, and innovative mixed paradigm products based on visual reinforcement of motor imagination-brain-computer interface upper and lower limb active and passive rehabilitation system.China's trade account in November was 692.8 billion yuan, with the previous value of 679.1 billion yuan.

 GD Helicopter Finance signed a financing agreement of over 77 million euros. According to G&D Airlines, GD Helicopter Finance signed a financing agreement of over 77 million euros with Bank of China, London Branch and German Helaba Bank to support GDHF in purchasing several new Airbus H160 helicopters.General Administration of Customs: In the first 11 months, the import and export of private enterprises was 21.99 trillion yuan, accounting for 55.3% of China's total foreign trade. According to the data of the General Administration of Customs, in the first 11 months, the import and export of private enterprises was 21.99 trillion yuan, up 8.7%, accounting for 55.3% of China's total foreign trade, up 2 percentage points over the same period last year. Among them, the export was 14.86 trillion yuan, up 9.2%, accounting for 64.5% of China's total export value; Imports amounted to 7.13 trillion yuan, up 7.9%, accounting for 42.6% of China's total import value. In the same period, the import and export of foreign-invested enterprises reached 11.67 trillion yuan, up by 1.1%, accounting for 29.3% of China's total foreign trade. Among them, exports were 6.36 trillion yuan, an increase of 2.1%; Imports reached 5.31 trillion yuan, down 0.1%. The import and export of state-owned enterprises was 6.04 trillion yuan, down 0.7%, accounting for 15.2% of China's total foreign trade. Among them, the export was 1.79 trillion yuan, an increase of 3.9%; Imports were 4.25 trillion yuan, down 2.5%. (General Administration of Customs)

 The increase of inter-bank interest rate bonds continued to expand. The yield of China's 10-year active bond 240011 hit a new low of 1.86%, falling by 4.50 basis points in the day.Significant progress in domestic growth hormone! Jichuan Pharmaceutical Co., Ltd. and Tianjing Biological Co., Ltd. announced that the listing application of Etan long-acting growth hormone was accepted, with a height of 10.76 cm a year, which made significant progress in domestic growth hormone. Today, Tianjing Bio and Jichuan Pharmaceutical jointly announced that the application for marketing biological products of Etan long-acting recombinant human growth hormone injection (hereinafter referred to as "Etan long-acting growth hormone") for treating children's growth hormone deficiency (PGHD) has been accepted by NMPA. As the first and only long-acting growth hormone with fusion protein in the domestic application stage and listed products, this innovative therapy is expected to provide safe, effective and convenient treatment options for children with growth hormone deficiency. Etan long-acting growth hormone adopts innovative hyFc® fusion protein technology, which greatly improves the stability and half-life of the drug by combining human growth hormone with specially designed human immunoglobulin. This patented technology not only ensures the biological activity of growth hormone, but also realizes the long-acting function of growth hormone in the body, thus making Ethan the first fusion protein long-acting growth hormone to be administered once a week.